Form 8-K Atara Biotherapeutics, For: Aug 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Wall St futures rise as Treasury yields cool, oil slips
- Oil slips as Mideast exports, G7 stockpile ease supply concerns
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Citi cuts investment banking analyst program to two years - Bloomberg
- Paramount Skydance to close WBD deal, change ticker to SKYD
- HubSpot to cut 7% of workforce in restructuring plan
- Nasdaq notches record high close as investors focus on earnings
- Francis Halzen wins Nobel Physics Prize for Antarctic 'ghost particle' hunt
ATARA Biotherapeutics (ATRA) Misses Q2 EPS by 18c
August 6, 2015 6:49 AM EDTATARA Biotherapeutics (NASDAQ: ATRA) reported Q2 EPS of ($0.62), $0.18 worse than the analyst estimate of ($0.44).
For earnings history and earnings-related data on ATARA Biotherapeutics (ATRA) click here.
... More


